John J. Kirby
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About John J. Kirby
John J. Kirby is recorded as CFO at Verrica Pharmaceuticals Inc. (VRCA). Verrica Pharmaceuticals Inc. reported in an 8-K filed November 4, 2024 that John J. Kirby was appointed Interim Chief Financial Officer, effective November 5, 2024. The proxy statement of Verrica Pharmaceuticals Inc. reports total compensation of $614,600 for John J. Kirby in fiscal 2025, including a base salary of $480,000. Disclosed compensation is on record for 2 fiscal years.
“On November 1, 2024, the Board appointed John J. Kirby as the Company's Interim Chief Financial Officer and designated him as the Company's interim principal financial officer and interim principal accounting officer, each effective as of the Effective Date.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-11-05–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Verrica Pharmaceuticals Inc.
Other people whose current roles at this company are on record from its filings.
- Dr. Jayson Rieger CEO, Board Member
- Jayson Rieger CEO, Board Member
- John Kirby CFO
- Terry Kohler CFO, Chief Accounting Officer
- David Zawitz COO
- Charles Frantzreb Board Member
- Diem Nguyen Board Member
- Gavin Corcoran Board Member
- Lawrence Eichenfield Board Member
- Paul B. Manning Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Verrica Pharmaceuticals Inc. (VRCA) | Interim Chief Financial Officer | $480,000 | $614,600 |
| 2024 | Verrica Pharmaceuticals Inc. (VRCA) | Interim Chief Financial Officer | $73,333 | $114,587 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.